---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-037130"
form_type: "8-K"
ticker: "SINT"
cik: "0001269026"
company_name: "Sintx Technologies, Inc."
filed_at: "2026-08-11T20:10:37+00:00"
generated_at: "2026-08-11T20:12:29.053061+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# SINTX guides Q3-Q4 2026 revenue of $0.9M-$1.3M per quarter; $3.2M industrial orders

## Summary
- Q3 2026 revenue guided to $0.9M-$1.1M; Q4 2026 to $1.0M-$1.3M, subject to delivery and customer acceptance.
- Received ~$3.2M in H1 2026 industrial purchase orders from contract manufacturers; revenue recognition expected from Q3 2026.
- SiNAPTIC Foot & Ankle Wedge System (FDA 510(k) cleared Oct 2025) in Limited Use Release; 12 independent orthopedic distributors engaged.
- Q2 2026 financing raised ~$5.0M gross via private placement and ATM facility to fund commercialization and operations.
- NIH granted 12-month extension to access ~$745K remaining on $1.97M grant for porous SiN/PEEK spinal implant development.

## SEC filing metadata
- accession: 0001493152-26-037130
- form_type: 8-K
- ticker: SINT
- cik: 0001269026
- company_name: Sintx Technologies, Inc.
- filed_at: 2026-08-11T20:10:37+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1269026/000149315226037130/0001493152-26-037130-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1269026/000149315226037130/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-037130
- JSON: https://secwatch.observer/filing/0001493152-26-037130.json
- Plain text: https://secwatch.observer/filing/0001493152-26-037130.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.